| Literature DB >> 17822826 |
Anne De Cian1, Laurent Lacroix, Céline Douarre, Nassima Temime-Smaali, Chantal Trentesaux, Jean-François Riou, Jean-Louis Mergny.
Abstract
Telomeres and telomerase represent, at least in theory, an extremely attractive target for cancer therapy. The objective of this review is to present the latest view on the mechanism(s) of action of telomerase inhibitors, with an emphasis on a specific class of telomere ligands called G-quadruplex ligands, and to discuss their potential use in oncology.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17822826 DOI: 10.1016/j.biochi.2007.07.011
Source DB: PubMed Journal: Biochimie ISSN: 0300-9084 Impact factor: 4.079